Prospective, randomized, double-blind, multi-center, Phase III clinical study on transarterial chemoembolization (TACE) combined with Sorafenib versus TACE plus placebo in patients with hepatocellular cancer before liver transplantation - HeiLivCa [ (Q33387430)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Prospective, randomized, double-blind, multi-center, Phase III clinical study on transarterial chemoembolization (TACE) combined with Sorafenib versus TACE plus placebo in patients with hepatocellular cancer before liver transplantation - HeiLivCa [ |
scientific article |
Statements
1 reference
Prospective, randomized, double-blind, multi-center, Phase III clinical study on transarterial chemoembolization (TACE) combined with Sorafenib versus TACE plus placebo in patients with hepatocellular cancer before liver transplantation - HeiLivCa [ (English)
1 reference
M W Büchler
1 reference
K Hoffmann
1 reference
H Glimm
1 reference
B Radeleff
1 reference
G Richter
1 reference
C Heining
1 reference
I Schenkel
1 reference
A Zahlten-Hinguranage
1 reference
P Schirrmacher
1 reference
J Schmidt
1 reference
D Jaeger
1 reference
C von Kalle
1 reference
P Schemmer
1 reference
26 November 2008
1 reference
1 reference
349
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference